KUBIENT, INC. Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2023-03-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2023-03-31..
- Interest coverage · 12 months: Value -1320.46×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2023-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2023-03-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2023-03-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | -1320.46× | Operating income ÷ reported interest expense. $-12.52M ÷ $9.48K ≈ -1320.46× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -12.52M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 9.48K USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | (m) | (m) | (m) | $-12.52M | $9.48K | (m) | (m) | -1320.46× | Reported |
| 2022-12-31 | (m) | (m) | (m) | $-14.25M | $10.91K | (m) | (m) | -1306.40× | Reported |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | $-12.76M | $10.62K | (m) | (m) | -1201.69× | Reported |
| 2021-12-31 | (m) | (m) | (m) | $-10.37M | $8.38K | (m) | (m) | -1237.28× | Reported |
| 2021-09-30 | (m) | (m) | (m) | $-8.04M | $18.87K | (m) | (m) | -426.24× | Reported |
| 2021-06-30 | (m) | (m) | (m) | $-7.15M | $409.49K | (m) | (m) | -17.45× | Reported |
| 2021-03-31 | (m) | $2.43M | (m) | $-6.53M | $704.43K | (m) | (m) | -9.27× | Reported |
| 2020-12-31 | (m) | $1.30M | $468.22K | (m) | (m) | (m) | 36.01% | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | $-3.23M | $1.34M | (m) | (m) | -2.41× | Reported |
| 2020-06-30 | (m) | (m) | (m) | $-2.76M | $1.31M | (m) | (m) | -2.10× | Reported |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $27.27K | $-3.32M | $740.26K | (m) | (m) | -4.48× | Reported |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.